| Literature DB >> 35143525 |
Yezhe Lin1, Ivan De Araujo2, Gelsina Stanley3,4, Dana Small3,4, Paul Geha1,3,4.
Abstract
Chronic pain is associated with anhedonia and decreased motivation. These behavioral alterations have been linked to alterations in the limbic brain and could explain the increased risk for obesity in pain patients. The mechanism of these behavioral changes and how they set in in relation to the development of chronic pain remain however poorly understood. Here we asked how eating behavior was affected in low-back pain patients before and after they transitioned to chronic pain, compared to patients whose pain subsided. Additionally, we assessed how the hedonic perception of fat-rich food, which is altered in chronic pain patients, related to the properties of the nucleus accumbens in this patients' population. We hypothesized that the accumbens would be directly implicated in the hedonic processing of fat-rich food in pain patients because of its well-established role in hedonic feeding and fat ingestion, and its emerging role in chronic pain. Accordingly, we used behavioral assays and structural brain imaging to test sub-acute back pain patients (SBP) and healthy control subjects at baseline and at approximately one-year follow-up. We also studied a sample of chronic low-back pain patients (CLBP) at one time point only. We found that SBP patients who recovered at follow-up (SBPr) and CLBP patients showed disrupted eating behaviors. In contrast, SBP patients who persisted in having pain at follow-up (SBPp) showed intact eating behavior. From a neurological standpoint, only SBPp and CLBP patients showed a strong and direct relationship between hedonic perception of fat-rich food and nucleus accumbens volume. This suggests that accumbens alterations observed in SBPp patients in previous works might protect them from hedonic eating disruptions during the early course of the illness. We conclude that disrupted eating behavior specifically sets in after pain chronification and is accompanied by structural changes in the nucleus accumbens.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35143525 PMCID: PMC8830732 DOI: 10.1371/journal.pone.0263527
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical characteristics of all groups baseline .
| Parameter | SBP (n = 51) | CLBP (n = 43) | HC (n = 36) | P Value |
|---|---|---|---|---|
| Age, y | 31.20 ± 1.65 | 33.79 ± 1.81 | 31.31 ± 1.97 | 0.46 |
| Male sex n, (%) | 31 (60.8%) | 17 (39.5%) | 20 (55.6%) | 0.11 |
| EHIS | 75.12 ± 6.74 | 74.03 ± 9.06 | 73.94 ± 7.52 | 0.45 |
| BMI, kg/m2 | 26.16 ± 0.80 | 24.38 ± 0.75 | 24.88 ± 0.86 | 0.38 |
| % Body fat | 1.05 ± 0.06 | 0.95 ± 0.07 | 1.03 ± 0.07 | 0.56 |
| Years of education | 15.65 ± 0.55 | 15.32 ± 0.63 | 15.16 ± 0.70 | 0.85 |
| BDI | 5.27 ± 1.67 | 7.61 ± 1.45 | 2.66 ± 1.98 |
|
| BAI | 6.63 ± 1.92 | 7.91 ± 1.95 | 3.41 ± 2.29 | 0.07 |
| BIS-11 | 55.61 ± 1.83 | 56.00 ± 2.29 | 55.48 ± 2.18 | 0.98 |
| BIS | 2.52 ± 0.12 | 2.52 ± 0.13 | 2.20 ± 0.10 | 0.05 |
| BAS | 1.93 ± 0.13 | 2.27 ± 0.16 | 2.24 ± 0.15 | 0.16 |
| TFEQ—Restraint | 9.24 ± 0.77 | 10.46 ± 0.95 | 8.57 ± 0.89 | 0.33 |
| TFEQ—Disinhibition | 5.15 ± 0.48 | 5.52 ± 0.57 | 4.53 ± 0.56 | 0.45 |
| TFEQ—Hunger | 5.22 ± 0.54 | 4.86 ± 0.65 | 4.17 ± 0.63 | 0.44 |
| PFS—Food availability | 11.63 ± 0.94 | 11.68 ± 1.19 | 12.52 ± 1.12 | 0.81 |
| PFS—Food presence | 14.32 ± 0.95 | 13.42 ± 1.15 | 15.86 ± 1.13 | 0.30 |
| PFS—Food tasted | 13.12 ± 0.76 | 12.45 ± 0.89 | 13.48 ± 0.90 | 0.70 |
| BES | 4.98 ± 2.31 | 11.72 ± 5.43 | 5.04 ± 2.76 | 0.15 |
| DEBQ | 1.99 ± 0.14 | 2.08 ± 0.15 | 1.85 ± 0.17 | 0.62 |
| IPAQ, h | 165.71 ± 24.22 | 156.2 ± 23.39 | 157.07 ± 28.08 | 0.96 |
| YFAS | 1.15 ± 0.12 | 1.55 ± 0.20 | 1.23 ± 0.17 | 0.22 |
| VAS pain | 3.38 ± 0.29 | 4.50 ± 0.33 | - | 0.010 |
| Pain duration, weeks | 9.82 ± 29.10 | 281.9 ± 45.43 | - | <0.0001 |
| Pain DETECT questionnaire | 6.18 ± 0.86 | 7.42 ± 0.96 | - | 0.28 |
| MPQ—Total | 8.81 ± 0.84 | 10.11 ± 0.76 | - | 0.26 |
| MPQ—Sensory | 6.47 ± 0.72 | 7.30 ± 0.69 | - | 0.42 |
| MPQ—Affective | 2.43 ± 0.48 | 2.80 ± 0.55 | - | 0.56 |
| NPS—Total | 21.82 ± 2.09 | 28.20 ± 2.43 | - | 0.045 |
Abbreviations: CLBP, chronic low back pain; SBP, subacute back pain; HC, Healthy Control; EHIS, Edinburgh Handedness Inventory Score; BMI, body mass index; BDI, Beck Depression Index; BAI, Beck Anxiety Index; BIS-11, Barratt Impulsiveness Scale; BIS, Behavioral Inhibition System; BAS, Behavioral Activation System; TFEQ, Three Factor Eating Questionnaire; PFS, Power of Food Scale; BES, Binge Eating Scale; DEBQ, Dutch Eating Behavioral Questionnaire; IPAQ, International Physical Activity Questionnaire; VAS, visual analog scale; MPQ, McGill Pain Questionnaire; PFS, Power of Food Scale; NPS, Neuropathic Pain Scale; YFAS, Yale Food Addiction Scale.
a, Values are expressed as mean ± standard error of mean or n (%).
b, Calculated by t test, Mann-Whitney Rank Sum Test or χ2 test.
Note:
* Statistically significant; data available for years of education: 32 in SBP, 24 in CLBP, and 19 in HC; Subjects who finished session 2 were included in our main results.
Demographic and clinical characteristics of SBP patients at baseline .
| Parameter | SBPr (n = 20) | SBPp (n = 16) | HC (n = 36) | P Value |
|---|---|---|---|---|
| Age, y | 30.60 ± 2.20 | 34.30 ± 2.40 | 30.60 ± 2.00 | 0.35 |
| Male sex n, (%) | 12 (60.0%) | 10 (62.5%) | 20 (55.6%) | 0.88 |
| EHIS | 76.75 ± 9.28 | 70.00 ± 10.37 | 62.67 ± 7.88 | 0.50 |
| BMI, kg/m2 | 24.75 ± 1.15 | 26.79 ± 1.28 | 25.36 ± 0.93 | 0.48 |
| % Body fat | 0.94 ± 0.09 | 1.13 ± 0.10 | 1.03 ± 0.07 | 0.36 |
| Years of education | 15.71 ± 0.87 | 15.71 ± 4.53 | 15.16 ± 0.7 | 0.85 |
| BDI | 6.85 ± 1.06 | 2.81 ± 0.82 | 2.66 ± 1.98 |
|
| BAI | 7.80 ± 1.84 | 4.50 ± 0.74 | 3.41 ± 2.29 |
|
| BIS-11 | 55.50 ± 1.98 | 57.31 ± 3.19 | 55.48 ± 2.18 | 0.83 |
| BIS | 2.13 ± 0.17 | 2.30 ± 0.12 | 2.20 ± 0.10 | 0.23 |
| BAS | 2.00 ± 0.20 | 1.88 ± 0.12 | 2.24 ± 0.15 | 0.45 |
| TFEQ—Restraint | 8.85 ± 1.09 | 8.81 ± 1.17 | 8.57 ± 0.89 | 0.93 |
| TFEQ—Disinhibition | 5.15 ± 0.59 | 5.50 ± 0.87 | 4.53 ± 0.56 | 0.85 |
| TFEQ—Hunger | 5.90 ± 0.84 | 4.69 ± 0.93 | 4.17 ± 0.63 | 0.27 |
| PFS—Food availability | 12.25 ± 1.11 | 11.13 ± 1.45 | 12.52 ± 1.12 | 0.83 |
| PFS—Food presence | 16.30 ± 1.32 | 12.88 ± 1.50 | 15.86 ± 1.13 | 0.24 |
| PFS—Food tasted | 14.05 ± 1.05 | 12.69 ± 1.07 | 13.48 ± 0.90 | 0.77 |
| BES | 4.79 ± 0.85 | 5.00 ± 1.26 | 5.04 ± 2.76 | 0.91 |
| DEBQ | 1.94 ± 0.23 | 2.11 ± 0.25 | 1.85 ± 0.17 | 0.81 |
| IPAQ, h | 175.85 ± 25.11 | 98.95 ± 16.47 | 157.07 ± 28.08 | 0.16 |
| YFAS | 1.30 ± 0.20 | 1.06 ± 0.22 | 1.23 ± 0.17 | 0.71 |
| VAS pain | 3.64 ± 0.40 | 3.03 ± 0.43 | - | 0.31 |
| Pain duration, week | 9.16 ± 0.94 | 9.98 ± 0.99 | - | 0.55 |
| Pain DETECT questionnaire | 6.66 ± 1.04 | 5.87 ± 1.10 | - | 0.61 |
| MPQ—Total | 9.39 ± 1.12 | 7.95 ± 1.18 | - | 0.38 |
| MPQ—Sensory | 5.83 ± 1.00 | 6.91 ± 1.06 | - | 0.47 |
| MPQ—Affective | 3.56 ± 0.67 | 1.27 ± 0.71 | - |
|
| NPS—Total | 22.96 ± 2.78 | 20.85 ± 2.95 | - | 0.61 |
Abbreviations: SBPr, subacute back pain recovered; SBPp, subacute back pain persistent; HC, Healthy Control.
a, Values are expressed as mean ± standard error of mean or n (%).
b, Calculated by t test, Mann-Whitney Rank Sum Test, ANOVA, Kruskal-Wallis One Way Analysis of Variance or χ2 test.
Note:
* Statistically significant; data available for years of education: 14 in SBPr, 14 in SBPp, and 19 in HC; Subjects who finished session 2 were included in our main results.
Demographic and clinical characteristics of SBP patients at follow-up .
| Parameter | SBPr (n = 16) | SBPp (n = 13) | HC (n = 16) | P Value |
|---|---|---|---|---|
| Age, y | 33.69 ± 2.50 | 38.77 ± 2.77 | 31.88 ± 2.50 | 0.18 |
| Male sex n, (%) | 8 (50.0%) | 8 (61.5%) | 7 (43.75%) | 0.82 |
| BMI, kg/m2 | 25.35 ± 1.00 | 27.50 ± 8.70 | 24.83 ± 1.51 | 0.46 |
| % Body fat | 0.94 ± 0.09 | 1.16 ± 0.12 | 0.96 ± 0.10 | 0.28 |
| BDI | 4.20 ± 1.34 | 3.69 ± 1.44 | 2.38 ± 3.84 | 0.60 |
| BAI | 4.67 ± 1.53 | 4.23 ± 1.64 | 3.81 ± 1.48 | 0.92 |
| BIS-11 | 52.60 ± 1.81 | 55.23 ± 2.89 | 51.56 ± 2.00 | 0.46 |
| BIS | 3.18 ± 0.40 | 2.51 ± 0.15 | 2.78 ± 0.26 | 0.22 |
| BAS | 3.23 ± 0.10 | 3.14 ± 0.13 | 3.41 ± 0.12 | 0.33 |
| TFEQ—Restraint | 9.93 ± 1.39 | 9.42 ± 1.28 | 8.94 ± 1.24 | 0.86 |
| TFEQ—Disinhibition | 4.67 ± 0.64 | 5.17 ± 1.17 | 5.00 ± 0.92 | 0.94 |
| TFEQ—Hunger | 4.20 ± 0.87 | 3.77 ± 0.89 | 4.63 ± 0.82 | 0.78 |
| PFS—Food availability | 10.60 ± 0.95 | 9.69 ± 1.21 | 11.31 ± 1.29 | 0.70 |
| PFS—Food presence | 13.33 ± 1.47 | 12.31 ± 1.46 | 12.69 ± 1.47 | 0.90 |
| PFS—Food tasted | 11.73 ± 1.08 | 11.69 ± 1.15 | 11.38 ± 1.11 | 0.97 |
| BES | 2.67 ± 1.14 | 3.00 ± 1.37 | 1.27 ± 1.07 | 0.50 |
| DEBQ | 1.67 ± 0.19 | 2.22 ± 0.25 | 1.95 ± 0.28 | 0.44 |
| IPAQ, h | 131.04 ± 13.94 | 158.40 ± 52.74 | 103.19 ± 29.51 | 0.47 |
| YFAS | 1.00 ± 0.17 | 1.00 ± 0.19 | 1.13 ± 0.18 | 0.83 |
| VAS pain | 1.45 ± 0.31 | 3.55 ± 0.47 | - |
|
| Pain duration, week | - | 93.62 ± 11.23 | - | - |
| Pain DETECT questionnaire | 4.01 ± 0.90 | 6.74 ± 1.40 | - | 0.15 |
| MPQ—Total | 4.53 ± 1.35 | 7.99 ± 0.98 | - | 0.06 |
| MPQ—Sensory | 2.36 ± 0.54 | 5.67 ± 1.00 | - |
|
| MPQ—Affective | 2.16 ± 1.09 | 2.34 ± 0.67 | - | 0.90 |
| NPS—Total | 10.90 ± 3.86 | 20.72 ± 3.52 | - | 0.07 |
a, Values are expressed as mean ± standard error of mean or n (%).
b, Calculated by t test, Mann-Whitney Rank Sum Test, ANOVA, Kruskal-Wallis One Way Analysis of Variance or χ2 test.
Note:
* Subjects who finished session 2 were included in our main results.
Caloric consumption during session 2.
| Baseline | Follow-up | |||
|---|---|---|---|---|
| Calories from Mac and Cheese | Calories from Pudding | Calories from Mac and Cheese | Calories from Pudding | |
| CLBP | 367.18 ± 16.25 | 207.92 ± 40.39 | - | - |
| SBP | 359.62 ± 18.16 | 271.74 ± 44.50 | ||
| HC | 388.06 ± 18.53 | 296.00 ± 46.63 | ||
|
| - | - | ||
| SBPr | 363.65 ± 22.36 | 237.30 ± 60.80 | 370.75 ± 26.96 | 252.15 ± 77.13 |
| SBPp | 372.33 ± 26.73 | 185.72 ± 72.66 | 333.37 ± 29.81 | 190.59 ± 61.44 |
| HC | 388.06 ± 18.53 | 296.00 ± 46.63 | 386.95 ± 25.65 | 358.97 ± 64.33 |
|
| ||||